Emilie Darrigues Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
ARA Fellow
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Emilie Darrigues' research focuses on cancer, particularly glioblastoma and brain metastases, utilizing organoid models for precision medicine. Her work investigates the role of specific genes, such as PCK2, in T cell metabolic plasticity within the glioblastoma microenvironment. Darrigues also explores the enhancement of immune cell function and targeting of regulatory T cells using gold nanorods, a nanotechnology application in cancer therapy. She has contributed to studies on the genomic and transcriptomic profiling of brain metastases and the development of brain tumor biobanks, highlighting the importance of the neurosurgeon's role in these initiatives. Her scholarship metrics include an h-index of 9 with 13 publications and 267 citations. Key collaborators include Analiz Rodriguez, Madison P. Lee, Annick De Loose, and Murat Gökden, all from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 9
- Publications: 13
- Citations: 271
Selected Publications
-
1211 Defining the role of PCK2 in T cell metabolic plasticity in Glioblastoma (2023)
-
Genomic and Transcriptomic Profiling of Brain Metastases (2021)
-
Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion (2021)
-
Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells (2021)
-
Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon (2021)
Collaboration Network
Top Collaborators
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- 1211 Defining the role of PCK2 in T cell metabolic plasticity in Glioblastoma
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells
- Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells
- Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells
- Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells
- Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells
Similar Researchers
Based on overlapping research topics